The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Diukova G.M.

Kafedra nervnykh bolezneĭ fakul'teta postdiplomnogo professional'nogo obrazovaniia

Golubev V.L.

Kafedra nervnykh bolezneĭ FPPOV;
GOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova", Moskva

Pogromov A.P.

Sechenov First Moscow State Medical University, Moscow, Russia

Mnatsakanyan M.G.

Sechenov First Moscow State Medical University, Moscow, Russia

Functional disorders: pathogenesis and systematic of clinical presentation

Authors:

Diukova G.M., Golubev V.L., Pogromov A.P., Mnatsakanyan M.G.

More about the authors

Read: 4338 times


To cite this article:

Diukova GM, Golubev VL, Pogromov AP, Mnatsakanyan MG. Functional disorders: pathogenesis and systematic of clinical presentation. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(12):137‑144. (In Russ.)
https://doi.org/10.17116/jnevro2016116121137-144

Recommended articles:
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Pathogenesis of fibrosis deve­lopment in ovarian endo­metriosis. Russian Journal of Archive of Pathology. 2025;(2):73-78
Portopulmonary hype­rtension. Journal of Respiratory Medi­cine. 2025;(2):39-44
Bacterial vagi­nosis: modern views. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):261-268
Study of the role of inte­rleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):421-424
Endo­metriosis-associated infe­rtility and the effi­cacy of dienogest. Russian Journal of Human Reproduction. 2025;(5):58-63
Rosa­cea: from multifactorial pathogenesis to modern treatment methods. Russian Journal of Clinical Dermatology and Vene­reology. 2026;(1):23-30

References:

  1. Stone J, Carson A, Duncan R, Coleman R, Roberts R, Warlow C, Hibberd C, Murray G, Cull R, Pelosi A, Cavanagh J, Matthews K, Goldbeck R, Smyth R, Walker J, MacMahon AD, Sharpe M. Symptoms ‘unexplained by organic disease’ in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009;132:2878-2888. doi: doi: 10.1093/brain/awp220
  2. Stone J, Carson A, Duncan R, Coleman R, Roberts R, Warlow C et al. Who is referred to neurology clinics? — the diagnoses made in 3781 new patients. Clin Neurol Neurosurg. 2010;112(9):747-751. doi: doi: 10.1016/j.clineuro.2010.05.011
  3. Perkin GD. An analysis of 7836 successive new outpatient referrals. J Neurol Neurosurg Psychiatr. 1989;52:447-448. doi: 10.1136/jnnp.52.4.447
  4. Brandt T, Dieterich M, Strupp M. Psychogenic Forms of Vertigo and Dizziness. In Book «Vertigo and Dizziness. Common Complaints». Springer. 2005;115-122. doi: 10.1007/1-84628-081-8_5
  5. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712-721. doi: doi: 10.1016/j.cgh.2012.02.029
  6. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Alimentary Pharmacology & Therapeutics. 2004;20:7:31-39. doi: 10.1111/j.1365-2036.2004.02183
  7. Pogromov AP, Mnatsakanyan MG On the question of the prevalence of irritable bowel syndrome in the Russian Federation. Clinical Medicine. 2016; (In Russ.).
  8. ABC of Medically Unexplained Symptoms. January Ed. Christopher Burton. 2013, BMJ Books. ISBN: 978-1-119-96725-5.(монография)
  9. Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Archives of General Psychiatry. 2005;62:903-910. doi: 10.1001/archpsyc.62.8.903
  10. Delius L, Fahrenberg J. Psychovegetative Syndrome. Stuttgart: Thieme; 1966.
  11. International Statistical Classification of Diseases and Related Health Problems V: Mental and Behavioral Disorders, 10th Revision (ICD-10). Geneva, WHO,1992. (In Russ.).
  12. DSM III. Diagnostic and Statistical Manual of Mental Disorders. Revised Third Edition. Washington, 1980.
  13. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. By the American Psychiatric Association. APA: Washington, DC. 1994. doi: doi: 10.1017/S0033291700035765
  14. Sharpe M, Mayou R, Bass C. Concepts, theories and terminology. In: Treatment of functional somatic symptoms. (ed. Mayou R, Bass C. and Sharpe M). Oxford: Oxford University Press; 1995.
  15. Ursin H, Eriksen HR. Sensitization, subjective health complaints and sustained arousal. Ann N Y Acad Sci. 2001;933:119-129. doi: 10.1111/j.1749-6632.2001.tb05819.x
  16. Fink P, Toft T, Hansen MS, Ornbol E, Olesen F. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med. 2007;69:30-39. doi: 10.1097/PSY.0b013e31802e46eb
  17. Budtz-Lilly A, Schröder A, Rask MT, Fink P, Vestergaard M and Rosendal M. Bodily distress syndrome: A new diagnosis for functional disorders in primary care? BMC Family Practice. 2015;16:180. doi: 10.1186/s12875-015-0393-8
  18. Sarzi-Puttini P, Atzeni F, Di Franco M, Buskila D, Alciati A, Giacomelli C, Rossi A, Bazzichi L. Dysfunctional syndromes and fibromyalgia: a 2012 critical digest. Clin Exp Rheumatol. 2012;30(6 suppl 74):143-151. PMID: 23261014
  19. Woolf CJ. What is this thing called pain? J Clin Invest. 2010;120(11):3742-3744. doi: 10.1172/JCI45178
  20. Trimble M. Functional disease. BMJ. 1982;285:1768-1770. doi: doi: 10.1136/bmj.285.6357.1768
  21. DSM-5 Fifth Edition Of The Diagnostic And Statistical Manual Of Mental Disorders. 2013. doi: 10.1176/appi.books.9780890425596
  22. Aaron LA, Buchwald D. A Review of the Evidence for Overlap among Unexplained Clinical Conditions Ann Intern Med. 2001;134(9 Part 2):868-881. doi: 10.7326/0003-4819-134-9_Part_2-200105011-00011
  23. Goldenberg D, Simms R, Geiger A, Komaroff A. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum. 1990;33:381-387. doi: 10.1002/art.1780330311
  24. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354(11):936-939. doi: doi: 10.1016/S0140-6736(98)08320-2
  25. Rolfe A, Burton Ch. Epidemiology and Impact in Primary and Secondary Care. CHAPTER 2 in ABC of medically unexplained symptoms. Ed. by Ch Burton 2013 by John Wiley & Sons Ltd. pp. 5-6.
  26. Tashchayn OV, Mnatsakanyan MG, Pogromov AP, Diukova GM, Khalyapina DV, Morozova YN Associated symptoms in IBS patients. Medical advice. 2015;5:124-128. (In Russ.).
  27. Rodríguez MÁB, Afari N, Buchwald DS. A Review of the Evidence for Overlap between Urological and Nonurological Unexplained Clinical Conditions J Urol. 2009;182(5):2123-2131. doi: doi: 10.1016/j.juro.2009.07.036
  28. Walker EA, Gelfand AN, Gelfand MD, Green C, Katon WJ. Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome. J Psychosom Obstet Gynaecol. 1996;17:39-46. doi: 10.3109/01674829609025662
  29. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clinical Epidemiology. 2014;6:71-80. doi: doi: 10.2147/CLEP.S40245
  30. Stone J, Sharpe M, Rothwell PM, Warlow CP. The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2003;74:591-596. doi: 10.1136/jnnp.74.5.591
  31. Dinos S, Khoshaba B, Ashby D, White PD, Nazroo J, Wessely S, Bhui KS. A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. Int J Epidemiol. 2009;38:1554-1570. doi: 10.1093/ije/dyp147
  32. McCarberg BH. Clinical overview of fibromyalgia. Am J Ther. 2012;19:357-368. doi: 10.1097/MJT.0b013e3181ff7bee
  33. Chang L, Margaret M. Heitkemper Gender differences in irritable bowel syndrome. J Gastroenterology. 2002;123(5):1686-1701. doi: doi: 10.1053/gast.2002.36603
  34. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997;112:2120-2137. doi: doi: 10.1053/gast.1997.v112.agast972120
  35. Flier SN, Rose S. Is functional dyspepsia of particular concern in women? A review of gender differences in epidemiology, pathophysiologic mechanisms, clinical presentation, and management. Am J Gastroenterol. 2006;101:644-653. doi: 10.1111/j.1572-0241.2006.01015.x
  36. Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: Potential mechanisms of sex hormones. World J Gastroenterol. 2014;20(22):6725-6743. doi: 10.3748/wjg.v20.i22.6725
  37. Heitkemper M, Jarett M, Bond EF, Chang L. Impact of sex and gender on irritable bowel syndrome. Biol Res Nurs. 2003;5:56-65. doi: 10.1177/1099800403005001006
  38. Pogromov AP, Zuev V.M., Mnatsakanyan MG, Tashchyan OV Ovchinnikova DV Irritable bowel syndrome in women of reproductive age. Reproductive medicine (Kazakhstan). 2015;3-4(24-25):45-52. (In Russ.).
  39. Van der Kolk B, Posttraumatic stress disorder and the nature of trauma. Dialogues in Clinical Neuroscience. 2000;2:1:7-22.
  40. Sherin JE, Nemeroff CB. Post-traumatic stress disorder: the neurobiological impact of psychological trauma. Dialogues in Clinical Neuroscience. 2011;13:3:263-278.
  41. Videlock EJ, Adeyemo M, Licudine A, Hirano M, Ohning G, Mayer M, Mayer EA, Chang L Childhood trauma is associated with hypothalamic pituitary adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology. 2009;137:1954-1962. doi: doi: 10.1053/j.gastro.2009.08.058
  42. Felitti VJ et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14:245-258. doi: doi: 10.1016/S0749-3797(98)00017-8
  43. Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:131-139. doi: 10.5056/jnm.2011.17.2.131
  44. Heim C, Wagner D, Maloney E, Papanicolaou DA, Solomon L, Jones JF, Unger ER, Reeves WC. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry. 2006;63:1258-1266. doi: 10.1001/archpsyc.63.11.1258
  45. Drossman DA, Leserman J, Nachman G, Li Z, Gluck H, Toomey TC et al. Sexual and Physical Abuse in Women with Functional or Organic Gastrointestinal Disorders. Ann Intern Med. 1990;113:828-833. doi: 10.7326/0003-4819-113-11-828
  46. Heim C, Ehlert U, Hanker J, Hellhammer DH. Abuse-Related Posttraumatic Stress Disorder and Alterations of the Hypothalamic-Pituitary-Adrenal Axis in Women With Chronic Pelvic Pain Psychosomatic Medicine. 1998;60:3:309-318. doi: 10.1097/00006842-199805000-00017
  47. Roelofs K, Keijsers GPJ, Hoogduin KAL, Näring GWB, Moene FC. Childhood Abuse in Patients With Conversion Disorder. Am J Psychiatry. 2002;159:1908-1913. doi: 10.1176/appi.ajp.159.11.1908
  48. Smith PF, Darlington CL. Personality changes in patients with vestibular dysfunction. Front Hum Neurosci. 2013. doi.org.sci-hub.io/10.3389/fnhum.2013.00678
  49. Staab JP, Rohe DE, Eggers SDZ, Shepard NT. Anxious, introverted personality traits in patients with chronic subjective dizziness. Journal of Psychosomatic Research. 2014;76:80-83. doi: doi: 10.1016/j.jpsychores.2013.11.008
  50. Urs NM, Jones JF, Lin J-MS, Maloney E, Reeves WC, Heim C. Personality Features and Personality Disorders in Chronic Fatigue Syndrome: A Population-Based Study. Psychother Psychosom. 2010;79:312-318. doi: 10.1159/000319312
  51. http://www.neurosymptoms.org/-Functional and Dissociative Neurological Symptoms: a patient’s guide.
  52. Reid S, Chalder T, Cleare A, Hotopf M, Wessely S. Chronic fatigue syndrome. BMJ Clinical Evidence. 2008;08:1101.
  53. Arnold LM, Clauw DJ, Dunegan LJ, Turk DC, Fibro Collaborative. A Framework for Fibromyalgia Management for Primary Care Providers. Mayo Clin Proc. 2012;87(5):488-496. doi: doi: 10.1016/j.mayocp.2012.02.010
  54. Lembo AJ. Current and Emerging Therapies for Irritable Bowel Syndrome. Gastroenterology & Hepatology. 2015;11:4:9-15
  55. Demartini B, Batla A, Petrochilos P, Fisher L, Edwards MJ, Joyce E. Multidisciplinary treatment for functional neurological symptoms: a prospective study. J Neurol. 2014;261:2370-2377. doi: 10.1007/s00415-014-7495-4
  56. Fjorback LO, Arendt M, Ørnbøl E, Walach H, Rehfeld E, Schröder A, Fink P. Mindfulness therapy for somatization disorder and functional somatic syndromes — Randomized trial with one-year follow-up. J Psychosom Res. 2012. doi: 10.1016/j.jpsychores.2012.09.010
  57. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69(9):881-888. doi: 10.1097/PSY.0b013e31815b00c4
  58. Grover M, Drossman DA. Psychotropic agents in functional gastrointestinal disorders. Current Opinion in Pharmacology. 2008;8:715-723. doi: 10.1016/j.coph.2008.07.012
  59. Staab JP, Ruckenstein MJ, Amsterdam JD. A Prospective Trial of Sertraline for Chronic Subjective Dizziness. Laryngoscope. 2004;114:1637-1641. doi: 10.1097/00005537-200409000-00025
  60. Diukova GM, Adilova SM, Zamergrad MV Features of clinical manifestations of panic disorder, depending on the accompanying dizziness and efficacy of paroxetine in their therapy. Medical Board. 2014;10:70-75. (In Russ.).
  61. Balaban CD, Thayer JF Neurological bases for balance anxiety links. J Anxiety Disorders. 2001;15:53-79. doi: 10.1016/S0887-6185(00)00042-6
  62. Vuilleumier P. Hysterical conversion and brain function. Prog Brain Res. 2005;150:309-329. doi: 10.1016/S0079-6123(05)50023-2
  63. Schrag AE, Mehta AR, Bhatia KP, Brown RJ, Frackowiak RSJ, Trimble MR, Ward NS, Rowe JB. The functional neuroimaging correlates of psychogenic versus organic dystonia. Brain. 2013;136:770-781. doi: doi: 10.1093/brain/awt008
  64. Edwards MJ, Fotopoulou A. Paree´s I. Neurobiology of functional (psychogenic) movement disorders. Curr Opin Neurol. 2013;26:442-447. doi: 10.1097/WCO.0b013e3283633953
  65. Ricciardi I, Edwards M, Functional (psychogenic) movement disorders. In: Parkinson’s disease and movement disorders (sixth ed.), J. Jankovic, E. Tolosa. 2015.
  66. Leontiev DA. Psychology of freedom: to the problem of self-determination of the individual. Psychological Journal. 2000;21:1. (In Russ.).
  67. David N. Functional anatomy of the sense agency. In: Neuropsychology of the sense agency. 2010;69-86. doi: 10.1007/978-88-470-1587-6_4
  68. David N. New frontiers in the neuroscience of the sense agency. In: Frontiers in human neuroscience. 2012;6:1-4. doi: 10.3389/fnhum.2012.00161
  69. Moore J, Fletcher P. Sense agency in health and disease: a review of cue integration approaches. Consciousness and Cognition. 2012;21:1:59-68. doi: 10.1016/j.concog.2011.08.010
  70. Kranick S, Hallet M. Neurology of Volition. Review Exp Brain Res. 2013. doi: 10.1007/s00221-013-3399-2
  71. Pacherie E. Self-agency. In: The Oxford Handbook of the Self, Oxford University Press; 2010. doi: 10.1093/oxfordhb/9780199548019.003.0020
  72. Edwards M, Schrag A. Hyperkinetic psychogenic movement disorders. A. In: Handbook of clinical disorders. ELSEVIER; 2011;100(3 rd Series):719-729. doi: 10.1016/B978-0-444-52014-2.00051-3
  73. Haggard P, Chambon V. Sense of agency Current Biology. 2012;22:10:390-392. doi: doi: 10.1016/j.cub.2012.02.040
  74. Edwards M, Moretto G, Schwingenschuh P, Katschnig P, Bhatia K.P., Haggard P. Abnormal sense of intention preceding voluntary movement in patients with psychogenic tremor. Neuropsychologia. 2011;49:2791-2793. doi: 10.1016/j.neuropsychologia.2011.05.021
  75. Ingram RE. Self-focused attention in clinical disorders: review and a conceptual model. Psychological Bulletin. 1990;107:2:156-176. doi: 10.1037/0033-2909.107.2.156
  76. Bob P. Brain, Mind and Consciousness, Springer. 2011;142. doi: 10.1007/978-1-4614-0436-1
  77. Dreikurs R. Psychology in the classroom, (2nd edition), Harper and Row, New York. 1968. doi: 10.1002/1520-6807(196904)
  78. Edwards M, Bhatia K. Functional (psychogenic) movement disorders: merging mind and brain. Lancet/neurology. 2012;11:3:250-260. doi: doi: 10.1016/S1474-4422(11)70310-6
  79. Diukova GM, Golubev VL Neurological approaches to the diagnosis of hysteria. Journal of Neurology and Psychiatry. C.C. Korsakov. 1994;5:95-100. (In Russ.).
  80. Fahn S, Jankovic J, Hallet M. Psychogenic movement disorders. In: Principles and Practice of Movement Disorders. ELSEVIER. 2011;513-527. doi: 10.1016/b978-1-4377-2369-4.00025-1

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.